ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS)

CNY 27.72

(0.84%)

Revenue Summary of ChengDu ShengNuo Biotec Co.,Ltd.

  • ChengDu ShengNuo Biotec Co.,Ltd.'s latest annual revenue in 2023 was 430.98 Million CNY , up 8.91% from previous year.
  • ChengDu ShengNuo Biotec Co.,Ltd.'s latest quarterly revenue in 2024 Q3 was 138.89 Million CNY , up 48.35% from previous quarter.
  • ChengDu ShengNuo Biotec Co.,Ltd. reported a annual revenue of 395.71 Million CNY in annual revenue 2022, up 2.38% from previous year.
  • ChengDu ShengNuo Biotec Co.,Ltd. reported a annual revenue of 386.52 Million CNY in annual revenue 2021, up 2.05% from previous year.
  • ChengDu ShengNuo Biotec Co.,Ltd. reported a quarterly revenue of 102.73 Million CNY for 2024 Q1, down -27.84% from previous quarter.
  • ChengDu ShengNuo Biotec Co.,Ltd. reported a quarterly revenue of 93.62 Million CNY for 2024 Q2, down -8.86% from previous quarter.

Annual Revenue Chart of ChengDu ShengNuo Biotec Co.,Ltd. (2023 - 2017)

Historical Annual Revenue of ChengDu ShengNuo Biotec Co.,Ltd. (2023 - 2017)

Year Revenue Revenue Growth
2023 430.98 Million CNY 8.91%
2022 395.71 Million CNY 2.38%
2021 386.52 Million CNY 2.05%
2020 378.77 Million CNY 15.92%
2019 326.73 Million CNY 17.54%
2018 277.97 Million CNY 42.95%
2017 194.45 Million CNY 0.0%

Peer Revenue Comparison of ChengDu ShengNuo Biotec Co.,Ltd.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 95.536%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 85.188%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 99.429%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 97.19%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 94.956%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 94.47%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 94.758%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -118.963%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 98.229%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY 23.774%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 97.411%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY 33.177%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 92.028%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY 49.94%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 94.752%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 76.982%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY 64.572%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 92.197%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 97.207%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 95.852%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY 62.712%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 88.459%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 86.985%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY 16.441%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 84.485%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 91.146%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY 25.699%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 97.587%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 94.35%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY 49.016%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 95.741%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 95.784%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY 67.415%
China National Medicines Corporation Ltd. 49.69 Billion CNY 99.133%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 95.845%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 86.266%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -393.855%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 76.21%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY 40.75%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -47.639%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 90.041%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 86.26%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 90.342%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 69.92%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 98.959%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 89.699%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 73.535%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 86.082%
Guobang Pharma Ltd. 5.34 Billion CNY 91.943%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY 35.957%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 91.157%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 96.746%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 80.208%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 79.178%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 88.654%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 89.037%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY 53.763%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 96.388%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY -19.634%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 86.08%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY 53.171%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY 35.829%
CanSino Biologics Inc. 345.18 Million CNY -24.858%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 80.176%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 92.988%